Phytotherapy Research

Volume 27, Issue 4 p. 618-623

Research Article

Hypolipidemic Effects of Andrographolide and Neoandrographolide in Mice and Rats

Tao Yang,

Tao Yang

The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, The Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 201210 Shanghai, PRC

Shanghai R&D Centre for Standardization of Chinese Medicines, 201210 Shanghai, PRC

Institute of Liver Diseases, Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, 201210 Shanghai, PRC

Search for more papers by this author

Hai-xia Shi,

Hai-xia Shi

Traditional Chinese Medicine Department, Shanghai Third People's Hospital, School of Medicine, Shanghai Jiao Tong University

Search for more papers by this author

Zheng-tao Wang,

Zheng-tao Wang

Shanghai R&D Centre for Standardization of Chinese Medicines, 201210 Shanghai, PRC

Search for more papers by this author

Chang-hong Wang,

Corresponding Author

Chang-hong Wang

Shanghai R&D Centre for Standardization of Chinese Medicines, 201210 Shanghai, PRC

Correspondence to: Professor Chang-hong Wang, The Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 201210 Shanghai China

E-mail: [email protected]

Search for more papers by this author

Tao Yang,

Tao Yang

Shanghai R&D Centre for Standardization of Chinese Medicines, 201210 Shanghai, PRC

Institute of Liver Diseases, Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, 201210 Shanghai, PRC

Search for more papers by this author

Hai-xia Shi,

Hai-xia Shi

Traditional Chinese Medicine Department, Shanghai Third People's Hospital, School of Medicine, Shanghai Jiao Tong University

Search for more papers by this author

Zheng-tao Wang,

Zheng-tao Wang

Shanghai R&D Centre for Standardization of Chinese Medicines, 201210 Shanghai, PRC

Search for more papers by this author

Chang-hong Wang,

Corresponding Author

Chang-hong Wang

Shanghai R&D Centre for Standardization of Chinese Medicines, 201210 Shanghai, PRC

Correspondence to: Professor Chang-hong Wang, The Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 201210 Shanghai China

E-mail: [email protected]

Search for more papers by this author

First published: 29 June 2012

https://doi.org/10.1002/ptr.4771

Citations: 36

Read the full text

About

PDF

Tools

Share a link

Email
Facebook
Twitter
LinkedIn
Reddit
Wechat

Abstract

Andrographolide (AND) and neoandrographolide (NEO) are the diterpenoids from the Andrographis paniculata (Acanthaceae). It is reported the diterpenoids exhibit a wide spectrum of biological activities. The aim of this study was to investigate the hypolipidemic effect of AND and NEO in hyperlipidemic mice induced by 75% yolk emulsion and in hyperlipidemic rats induced by high fat emulsion, respectively. The results showed that the levels of triglyceride, total cholesterol (TC) and low-density lipoprotein cholesterol were reduced by AND and NEO in a dose-dependent tendency in mice. Compared with the model group, the plasma TC levels of experimental groups with AND and NEO at 100 mg/kg dosage decreased by 23.9 and 20.2% in rats, respectively (P < 0.05). It was also found that the plasma aspartate transaminase and alanine transaminase levels were significantly decreased by feeding with AND and NEO in rats, compared with positive group (simvastatin) (P < 0.01). Otherwise, AND and NEO could protect the cardiovascular due to down-regulation of iNOS expression and up-regulation of eNOS expression. In conclusion, AND and NEO have potent hypolipidemic effects and protect the cardiovascular without significant liver damage. Copyright © 2012 John Wiley & Sons, Ltd.

REFERENCES

Abu-Ghefreh AA, Canatan H, Ezeamuzie CI. 2009. In vitro and in vivo anti-inflammatory effects of andrographolide. Int Immunopharmacol 9: 313–318.
10.1016/j.intimp.2008.12.002
CASPubMedWeb of Science®Google Scholar
Al-Attar AM. 2010. Hypolipidemic effects of coenzyme Q10 in experimentally induced hypercholesterolemic model in female rats. Am JPharmTox 5: 14–23.

CASGoogle Scholar
Bader T. 2010. The myth of statin-induced hepatotoxicity. Am J Gastroenterol 105: 978–980.
10.1038/ajg.2010.102
PubMedWeb of Science®Google Scholar
Bao Z, Guan S, Cheng C, et al. 2009. A novel antiinflammatory role for andrographolide in asthma via inhibition of the nuclear factor-kappaB pathway. Am J Respir Crit Care Med 179: 657–665.
10.1164/rccm.200809-1516OC
CASPubMedWeb of Science®Google Scholar
Briel M, Ferreira-Gonzalez I, You JJ, et al. 2009. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. Brit Med J 338: b92–b92.
10.1136/bmj.b92
CASPubMedWeb of Science®Google Scholar
Chen JH, Hsiao G, Lee AR, Wu CC, Yen MH. 2004. Andrographolide suppresses endothelial cell apoptosis via activation of phosphatidyl inositol-3-kinase/Akt pathway. Biochem Pharmacol 67: 1337–1345.
10.1016/j.bcp.2003.12.015
CASPubMedWeb of Science®Google Scholar
Chern CM, Liou KT, Wang YH, Liao JF, Yen JC, Shen YC. 2011. Andrographolide inhibits PI3K/AKT-dependent NOX2 and iNOS expression protecting mice against hypoxia/ischemia-induced oxidative brain injury. Planta Med 77: 1669–1679.
10.1055/s-0030-1271019
CASPubMedWeb of Science®Google Scholar
China Pharmacopoeia Committee. 2010. Pharmacopoeia of the People's Republic of China. China Medical Science Press: Beijing China; 251.

Google Scholar
Chiou WF, Lin JJ, Chen CF. 1998. Andrographolide suppresses the expression of inducible nitric oxide synthase in macrophage and restores the vasoconstriction in rat aorta treated with lipopolysaccharide. Br J Pharmacol 125: 327–334.
10.1038/sj.bjp.0702073
CASPubMedWeb of Science®Google Scholar
Cohen DE, Anania FA, Chalasani N. 2006. An assessment of statin safety by hepatologists. Am J Cardiol 97: 77–81.
10.1016/j.amjcard.2005.12.014
CASPubMedWeb of Science®Google Scholar
Hsieh CY, Hsu MJ, Hsiao G, et al. 2011. Andrographolide enhances nuclear factor-kappaB subunit p65 Ser536 dephosphorylation through activation of protein phosphatase 2A in vascular smooth muscle cells. J Biol Chem 286: 5942–5955.
10.1074/jbc.M110.123968
CASPubMedWeb of Science®Google Scholar
Laufs U, La Fata V, Plutzky J, Liao JK. 1998. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97: 1129–1135.
10.1161/01.CIR.97.12.1129
CASPubMedWeb of Science®Google Scholar
Lin TP, Chen SY, Duh PD, Chang LK, Liu YN. 2008. Inhibition of the epstein-barr virus lytic cycle by andrographolide. Biol Pharm Bull 31: 2018–2023.
10.1248/bpb.31.2018
CASPubMedWeb of Science®Google Scholar
Rajagopal S, Kumar RA, Deevi DS, Satyanarayana C, Rajagopalan R. 2003. Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J Exp Ther Oncol 3: 147–158.
10.1046/j.1359-4117.2003.01090.x
CASPubMedGoogle Scholar
Refaie FM, Esmat AY, Gawad SM, Ibrahim AM, Mohamed MA. 2005. The antihyperlipidemic activities of 4(3 H) quinazolinone and two halogenated derivatives in rats. Lipids Health Dis 4: 22.
10.1186/1476-511X-4-22
PubMedGoogle Scholar
Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD. 2000. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. J Am Med Ass 284: 311–318.
10.1001/jama.284.3.311
CASPubMedWeb of Science®Google Scholar
Subramanian R, Asmawi MZ, Sadikun A. 2008. In vitro alpha-glucosidase and alpha-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide. Acta Biochim Pol 55: 391–398.
10.18388/abp.2008_3087
CASPubMedWeb of Science®Google Scholar
Trivedi NP, Rawal UM, Patel BP. 2007. Hepatoprotective effect of andrographolide against hexachlorocyclohexane-induced oxidative injury. Integr Cancer Ther 6: 271–280.
10.1177/1534735407305985
CASPubMedWeb of Science®Google Scholar
Wang JM, Ji LL, Liu H, Wang ZT. 2010. Study of the hepatotoxicity induced by Dioscorea bulbifera L. rhizome in mice. Biosci Trends 4: 79–85.

PubMedWeb of Science®Google Scholar
Xie WH, Sun C, Liu SM. 2009. Effect of hawthorn flavanone on blood-fat and expression of lipogenesis and lipolysis genes of hayprelipoliemia model mouse. China J Chin Mat Med 34: 224–229.

PubMedGoogle Scholar
Yang Y, Nie W, Yuan JM, et al. 2010. Genistein activates endothelial nitric oxide synthase in broiler pulmonary arterial endothelial cells by an Akt-dependent mechanism. Exp Mol Med 42: 768–776.
10.3858/emm.2010.42.11.078
CASPubMedWeb of Science®Google Scholar
Zhang HL, Tao Y, Guo J, Hu YM, Su ZQ. 2011. Hypolipidemic effects of chitosan nanoparticles in hyperlipidemia rats induced by high fat diet. Int Immunopharmacol 11: 457–461.
10.1016/j.intimp.2010.12.015
CASPubMedWeb of Science®Google Scholar

Citing Literature

Volume27, Issue4

April 2013

Pages 618-623

Hypolipidemic Effects of Andrographolide and Neoandrographolide in Mice and Rats

Abstract

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Hypolipidemic Effects of Andrographolide and Neoandrographolide in Mice and Rats

Abstract

REFERENCES

Citing Literature

References

Related

Information